Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tegafur

A congener of the antimetabolite fluorouracil with antineoplastic activity. Tegafur is a prodrug that is gradually converted to fluorouracil in the liver by the cytochrome P-450 enzyme. Subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells. FdUMP inhibits DNA synthesis and cell division by inhibiting thymidylate synthase and reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate.
US brand name:Florafur
Fluorofur
Foreign brand name:Citofur
Coparogin
Exonal
Fental
ftorafur
Ftoral
Ftoralon
Fulaid
Fulfeel
Furafluor
Furofutran
Futraful
Lamar
Lifril
Neberk
Nitobanil
Riol
Sinoflurol
Sunfural
Tefsiel
Utefos
Abbreviation:FT
Code name:FT-207
MJF-12264
WR-220066
Chemical structure:5-fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione
5-fluoro-1-(tetrahydro-2-furyl)-uracil
N1-(2'-furanidyl)-5-fluorouracil
IND number:10207
NSC code:148958
Search NCI's Drug Dictionary